Overview
Varsha Sharda is a Hematologist and an Oncologist in Rochester, New York. Dr. Sharda has been practicing medicine for over 43 years is highly rated in 12 conditions, according to our data. Her top areas of expertise are Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), Squamous Cell Lung Carcinoma, and ALK-Positive Non-Small Cell Lung Cancer.
Insurance
Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.
Locations
601 Elmwood Ave, Rochester, NY 14642
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
MediFind cannot find any recent clinical research or clinical trials for Dr. Varsha P. Sharda
University Of Rochester
Paul Barr is a Hematologist and an Oncologist in Rochester, New York. Dr. Barr is highly rated in 21 conditions, according to our data. His top areas of expertise are Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.
University Of Rochester
Jane Liesveld is a Hematologist and an Oncologist in Rochester, New York. Dr. Liesveld is highly rated in 43 conditions, according to our data. Her top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Leukemia, Bone Marrow Transplant, and Bone Marrow Aspiration.
University Of Rochester
Patrick Reagan is a Hematologist and an Oncologist in Rochester, New York. Dr. Reagan has been practicing medicine for over 16 years is highly rated in 18 conditions, according to our data. His top areas of expertise are Non-Hodgkin Lymphoma, Mantle Cell Lymphoma (MCL), B-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.
Areas of Expertise
When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
To learn more about how MediFind determines the expertise levels, check out our expert tiers page.
- Distinguished
- ALK-Positive Non-Small Cell Lung Cancer
- Lung Adenocarcinoma
- Small Cell Lung Cancer (SCLC)
- Squamous Cell Lung Carcinoma
- Advanced
- Angiosarcoma
- Breast Cancer
- EGFR Positive Lung Cancer
- Inflammatory Breast Cancer
- Large-Cell Lung Carcinoma
- Non-Small Cell Lung Cancer (NSCLC)
- Experienced
- Anal Cancer
- Breast Cancer in Men
- Colorectal Cancer
- Familial Colorectal Cancer
- Familial Pancreatic Cancer
- Gastroesophageal Junction Cancer